828 results on '"Stebbing, Justin"'
Search Results
2. Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study
3. CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growth
4. An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma
5. The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS
6. A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
7. Development of a Novel Pyroptosis-Associated lncRNA Biomarker Signature in Lung Adenocarcinoma
8. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
9. A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
10. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
11. The mutational landscape of the adult healthy parous and nulliparous human breast
12. Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer
13. Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial
14. Comparison of phenomics and cfDNA in a large breast screening population: the Breast Screening and Monitoring Study (BSMS)
15. A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data
16. Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas
17. PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38MAPK signalling
18. Identification of an immune gene-associated prognostic signature in patients with bladder cancer
19. Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report
20. Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients
21. The LMTK-family of kinases: Emerging important players in cell physiology and pathogenesis
22. Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial
23. Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients
24. The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate Cancer
25. LMTK3 inhibition affects microtubule stability
26. Correction to: LMTK3 inhibition affects microtubule Stability
27. PIK3C[delta] expression by fibroblasts promotes triple-negative breast cancer progression
28. Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation
29. Novel immunotherapeutic drugs for the treatment of lung cancer
30. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
31. Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma.
32. Afatinib treatment in a lung adenocarcinoma patient harboring a rare EGFR L747P mutation
33. CNS penetration of potential anti-COVID-19 drugs
34. Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours
35. Profiling circulating tumour cells and cell free DNA together in metastatic colon cancer
36. The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention
37. Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease
38. CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial
39. The relationship between ethnicity, social deprivation and late presentation of colorectal cancer
40. KSHV as a model of the host-pathogen equilibrium
41. Genes and Race in Colon Cancer.
42. LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).
43. Circulating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical Resection
44. LMTK3 confers chemo-resistance in breast cancer
45. A randomised trial comparing the pharmacokinetics and safety of the biosimilar CT-P6 with reference trastuzumab
46. Strategies in functional proteomics: Unveiling the pathways to precision oncology
47. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5
48. A cell-cycle signature classifier for pan-cancer analysis
49. Lessons to Europe from China for cancer treatment during the COVID-19 pandemic
50. Patient-derived xenograft models—the future of personalised cancer treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.